Megacaps most expensive in biotech sector

Within the biotech sector we see a low diversification of the 12-months returns. Since September last year the sector is around 23 percent higher. Among the winners we find Madrigal Pharmaceuticals, Mirati Therapeutics and Champions Oncology. Relatively big losses were for Orexigen Therapeutics, Faron Pharmaceuticals Oy and Celldex Therapeutics.

Core figures biotech sector

The large caps in this sector are the winners. Among the less performing we see mostly the microcaps.

Lowest PE-ratios biotech sector

Regarding the price/earings-ratios we see a spread palette. The megacaps are with the price/earnings-ratio of 24 the most expensive. The smallcaps are the cheapest and trade at -5 times the earnings per share. Oxford BioMedica, BioArctic AB and Bioventix are the stocks with the highest ratios. Stocks with the lowest ratios are Sprint Bioscience AB, BB Biotech AG and United Therapeutics.

Highest dividend yields biotech sector

The sector's average dividend yield is with 0,2 percent relatively limited. Stocks with now high dividend yields are BB Biotech AG, Gilead Sciences and Orior AG.

This is a free publication from Valuespectrum Pro. Valuespectrum Pro is a professional platform with analyses from all US and European companies. Click here to sign up for free.